Which has preferable valuation & earnings, DOCS or CERT?

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Doximity $644.86M 7.19 $196.05M $0.85 30.58 Certara $418.84M 3.07 -$1.60M -$0.45 N/A

Is DOCS or CERT more profitable?

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Doximity 25.48% 18.06% 15.40% Certara -16.75% 3.86% 2.65%

Does the media refer more to DOCS or CERT?

In the previous week, Doximity had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Doximity and 1 mentions for Certara. Doximity's average media sentiment score of 0.17 beat Certara's score of -0.40 indicating that Doximity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Doximity 4 Very Positive mention(s) 2 Positive mention(s) 11 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, WAY or CERT?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.48 $112.09M $0.70 36.66 Certara $418.84M 3.07 -$1.60M -$0.45 N/A

Is WAY or CERT more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Certara -16.75% 3.86% 2.65%

Does the media refer more to WAY or CERT?

In the previous week, Waystar had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Waystar and 1 mentions for Certara. Waystar's average media sentiment score of 0.31 beat Certara's score of -0.40 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 6 Very Positive mention(s) 4 Positive mention(s) 8 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, CERT or HTFL?

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Heartflow $176.03M 25.07 -$116.79M -$1.83 N/A

Is CERT or HTFL more profitable?

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Heartflow -55.82% -23.52% -18.66%

Does the media favor CERT or HTFL?

In the previous week, Heartflow had 28 more articles in the media than Certara. MarketBeat recorded 29 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.38 beat Certara's score of -0.40 indicating that Heartflow is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Heartflow 11 Very Positive mention(s) 7 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, CERT or SDGR?

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A Schrodinger $255.87M 8.37 -$103.26M -$0.74 N/A

Is CERT or SDGR more profitable?

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer CERT or SDGR?

In the previous week, Schrodinger had 12 more articles in the media than Certara. MarketBeat recorded 13 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.64 beat Certara's score of -0.40 indicating that Schrodinger is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Certara 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Schrodinger 5 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CERT or GDRX?

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Certara $418.84M 3.07 -$1.60M -$0.45 N/A GoodRx $796.85M 1.45 $30.44M $0.04 84.50

Is CERT or GDRX more profitable?

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Certara -16.75% 3.86% 2.65% GoodRx 2.07% 7.22% 2.53%

Certara (CERT) Competitors

$8.42 -0.16 (-1.86%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$8.49 +0.07 (+0.89%)

As of 09/18/2026 07:30 PM Eastern

Compare

CERT vs. DOCS, WAY, HTFL, SDGR, and GDRX

Should you buy Certara stock or one of its competitors? Certara's main competitors and comparable companies include Doximity (DOCS), Waystar (WAY), Heartflow (HTFL), Schrodinger (SDGR), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Certara compare to Doximity?

Doximity (NYSE:DOCS) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

Doximity has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Doximity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Doximity	$644.86M	7.19	$196.05M	$0.85	30.58
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A

Doximity presently has a consensus target price of $32.18, suggesting a potential upside of 23.80%. Certara has a consensus target price of $8.28, suggesting a potential downside of 1.69%. Given Doximity's higher probable upside, analysts plainly believe Doximity is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	2.31
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45

Doximity has a net margin of 25.48% compared to Certara's net margin of -16.75%. Doximity's return on equity of 18.06% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Doximity	25.48%	18.06%	15.40%
Certara	-16.75%	3.86%	2.65%

In the previous week, Doximity had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Doximity and 1 mentions for Certara. Doximity's average media sentiment score of 0.17 beat Certara's score of -0.40 indicating that Doximity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Doximity	4 Very Positive mention(s)	2 Positive mention(s)	11 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Doximity has a beta of 1.25, suggesting that its share price is 25% more volatile than the broader market. Comparatively, Certara has a beta of 1.4, suggesting that its share price is 40% more volatile than the broader market.

87.2% of Doximity shares are owned by institutional investors. Comparatively, 74.0% of Certara shares are owned by institutional investors. 31.8% of Doximity shares are owned by insiders. Comparatively, 1.1% of Certara shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Doximity beats Certara on 15 of the 17 factors compared between the two stocks.

How does Certara compare to Waystar?

Waystar (NASDAQ:WAY) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

74.0% of Certara shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 1.1% of Certara shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Certara	-16.75%	3.86%	2.65%

Waystar has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market. Comparatively, Certara has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market.

In the previous week, Waystar had 19 more articles in the media than Certara. MarketBeat recorded 20 mentions for Waystar and 1 mentions for Certara. Waystar's average media sentiment score of 0.31 beat Certara's score of -0.40 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	6 Very Positive mention(s)	4 Positive mention(s)	8 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.48	$112.09M	$0.70	36.66
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A

Waystar currently has a consensus price target of $34.67, suggesting a potential upside of 35.10%. Certara has a consensus price target of $8.28, suggesting a potential downside of 1.69%. Given Waystar's stronger consensus rating and higher probable upside, equities analysts clearly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45

Summary

Waystar beats Certara on 15 of the 17 factors compared between the two stocks.

How does Certara compare to Heartflow?

Certara (NASDAQ:CERT) and Heartflow (NASDAQ:HTFL) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, earnings, dividends, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

Certara currently has a consensus price target of $8.28, suggesting a potential downside of 1.69%. Heartflow has a consensus price target of $44.88, suggesting a potential downside of 11.58%. Given Certara's higher probable upside, analysts plainly believe Certara is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

In the previous week, Heartflow had 28 more articles in the media than Certara. MarketBeat recorded 29 mentions for Heartflow and 1 mentions for Certara. Heartflow's average media sentiment score of 0.38 beat Certara's score of -0.40 indicating that Heartflow is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Heartflow	11 Very Positive mention(s)	7 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Certara has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Heartflow	$176.03M	25.07	-$116.79M	-$1.83	N/A

Certara has a net margin of -16.75% compared to Heartflow's net margin of -55.82%. Certara's return on equity of 3.86% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Heartflow	-55.82%	-23.52%	-18.66%

74.0% of Certara shares are held by institutional investors. 1.1% of Certara shares are held by insiders. Comparatively, 7.7% of Heartflow shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Certara beats Heartflow on 9 of the 15 factors compared between the two stocks.

How does Certara compare to Schrodinger?

Certara (NASDAQ:CERT) and Schrodinger (NASDAQ:SDGR) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Certara has a beta of 1.4, suggesting that its stock price is 40% more volatile than the broader market. Comparatively, Schrodinger has a beta of 1.69, suggesting that its stock price is 69% more volatile than the broader market.

Certara currently has a consensus target price of $8.28, suggesting a potential downside of 1.69%. Schrodinger has a consensus target price of $20.50, suggesting a potential downside of 29.36%. Given Certara's stronger consensus rating and higher possible upside, analysts clearly believe Certara is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
Schrodinger	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.29

Certara has a net margin of -16.75% compared to Schrodinger's net margin of -20.98%. Certara's return on equity of 3.86% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
Schrodinger	-20.98%	-16.37%	-8.19%

Certara has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Certara, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
Schrodinger	$255.87M	8.37	-$103.26M	-$0.74	N/A

In the previous week, Schrodinger had 12 more articles in the media than Certara. MarketBeat recorded 13 mentions for Schrodinger and 1 mentions for Certara. Schrodinger's average media sentiment score of 0.64 beat Certara's score of -0.40 indicating that Schrodinger is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Certara	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Schrodinger	5 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

74.0% of Certara shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 1.1% of Certara shares are held by company insiders. Comparatively, 10.1% of Schrodinger shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Certara beats Schrodinger on 11 of the 17 factors compared between the two stocks.

How does Certara compare to GoodRx?

Certara (NASDAQ:CERT) and GoodRx (NASDAQ:GDRX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation, institutional ownership and media sentiment.

74.0% of Certara shares are owned by institutional investors. Comparatively, 63.8% of GoodRx shares are owned by institutional investors. 1.1% of Certara shares are owned by insiders. Comparatively, 5.9% of GoodRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Certara had 1 more articles in the media than GoodRx. MarketBeat recorded 1 mentions for Certara and 0 mentions for GoodRx. GoodRx's average media sentiment score of 0.00 beat Certara's score of -0.40 indicating that GoodRx is being referred to more favorably in the news media.

Company	Overall Sentiment
Certara	Neutral
GoodRx	Neutral

GoodRx has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Certara	$418.84M	3.07	-$1.60M	-$0.45	N/A
GoodRx	$796.85M	1.45	$30.44M	$0.04	84.50

Certara presently has a consensus price target of $8.28, indicating a potential downside of 1.69%. GoodRx has a consensus price target of $4.23, indicating a potential upside of 25.07%. Given GoodRx's higher possible upside, analysts clearly believe GoodRx is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Certara	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

GoodRx has a net margin of 2.07% compared to Certara's net margin of -16.75%. GoodRx's return on equity of 7.22% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Certara	-16.75%	3.86%	2.65%
GoodRx	2.07%	7.22%	2.53%

Certara has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market. Comparatively, GoodRx has a beta of 1.59, meaning that its share price is 59% more volatile than the broader market.

Summary

GoodRx beats Certara on 10 of the 16 factors compared between the two stocks.

Get Certara News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CERT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CERT vs. The Competition

Export

Metric	Certara	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.28B	$1.72B	$7.24B	$13.19B
Dividend Yield	N/A	4.71%	2.57%	12.81%
P/E Ratio	-18.71	20.07	275.49	25.40
Price / Sales	3.07	89.94	646.01	89.45
Price / Cash	11.13	31.60	76.25	51.42
Price / Book	1.26	6.14	10.46	6.33
Net Income	-$1.60M	-$18.66M	$3.49B	$358.33M
7 Day Performance	11.52%	1.79%	0.59%	1.12%
1 Month Performance	-3.55%	1.77%	-1.74%	-2.39%
1 Year Performance	-26.66%	-14.53%	18.13%	5.35%

Certara Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CERT Certara	0.9784 of 5 stars	$8.42 -1.9%	$8.28 -1.7%	-26.7%	$1.28B	$418.84M	N/A	1,576	High Trading Volume
DOCS Doximity	4.5287 of 5 stars	$26.38 +3.1%	$32.18 +22.0%	N/A	$4.56B	$644.86M	31.03	880	Trending News
WAY Waystar	4.3654 of 5 stars	$24.90 +6.1%	$35.14 +41.1%	-32.1%	$4.50B	$1.21B	35.57	1,700	Analyst Downgrade
HTFL Heartflow	2.0321 of 5 stars	$49.54 -0.7%	$44.88 -9.4%	+54.3%	$4.31B	$212.07M	N/A	843	News Coverage Insider Trade
SDGR Schrodinger	0.9604 of 5 stars	$20.75 +9.1%	$20.50 -1.2%	+49.2%	$1.40B	$259.04M	N/A	850	News Coverage Options Volume Gap Down High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CERT) was last updated on 9/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Certara (CERT) Competitors